腹腔镜袖状胃切除术与Roux-en-Y胃旁路术随机对照试验的系统综述与Meta分析
结果显示LRYGB在1年及3年BMI下降更显著,1年血脂异常缓解率更高,但5年证据不足。两组在2型糖尿病缓解、高血压缓解及生化指标等方面无差异。
要点
- LRYGB在1年及3年BMI下降优于LSG,5年证据不足。
- LRYGB在1年及5年血脂异常缓解率高于LSG。
- 两组2型糖尿病及高血压缓解、生化指标及30天并发症无差异。
核心结论
- LRYGB在1年及3年减重效果优于LSG,1年血脂异常缓解率更高,但5年长期比较证据不足。
主要发现
- LRYGB相比LSG在1年BMI下降更显著(均数差-1.25 kg/m2,95%CI -2.01至-0.49,P=0.001;中等证据质量),3年仍持续,但5年证据不足。
- LRYGB相比LSG在1年血脂异常缓解率更高(风险比0.58,95%CI 0.46-0.73,P<0.001;中等证据质量),5年亦更高(风险比0.68,95%CI 0.46-0.99,P=0.04;低证据质量)。
- 两组在2型糖尿病缓解、高血压缓解、糖化血红蛋白、空腹胰岛素、HOMA-IR、高密度脂蛋白及30天主要和次要并发症方面无差异。
关键数值与推荐
- LRYGB在1年BMI均数差为-1.25 kg/m2(95%CI -2.01至-0.49,P=0.001,中等证据质量)。
- LRYGB在1年血脂异常缓解风险比为0.58(95%CI 0.46-0.73,P<0.001,中等证据质量)。
- LRYGB在5年血脂异常缓解风险比为0.68(95%CI 0.46-0.99,P=0.04,低证据质量)。
临床怎么用
- 对于以减重和血脂异常改善为主要目标的患者,LRYGB可能优于LSG,但需结合患者个体情况与长期证据不确定性综合决策。
局限性
- 超过3年的长期比较效果证据不足,无法得出明确结论。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The aim of this study was to compare weight loss, obesity-related comorbidities, and biochemical outcomes of LSG versus LRYGB through a meta-analysis of randomized controlled trials (RCTs). SUMMARY OF BACKGROUND DATA: LSG and LRYGB are the 2 most commonly performed bariatric surgeries for the treatment of obesity. The comparative outcomes of the 2 surgeries is a topic of ongoing debate and medium-term outcomes remain uncertain. METHODS: A search for RCTs comparing LRYGB versus LSG was conducted. Pooled outcomes between 2 procedures were compared using pairwise random-effects meta-analysis at 1, 3, and 5-year follow-up time points. Grading of recommendations, assessment, development, and evaluation was used to assess certainty of evidence. RESULTS: Thirty-three studies involving 2475 patients were included. LRYGB resulted in greater loss of body mass index compared to LSG at 1 year [mean difference -1.25 kg/m2, 95% confidence interval (CI) -2.01 to -0.49, P = 0.001; moderate certainty of evidence] which persisted at 3 years, but there was insufficient evidence at 5 years. Resolution of dyslipidemia was higher for LRYGB than LSG at 1 year (risk ratio 0.58, 95% CI 0.46-0.73, P < 0.001; moderate certainty of evidence) and 5 years (risk ratio 0.68, 95%CI 0.46-0.99, P = 0.04; low certainty of evidence). There was no difference between LRYGB and LSG for remission of type 2 diabetes, hypertension, and hemoglobin A1c, fasting insulin, homeostatic model assessment of insulin resistance, high-density lipoprotein, and the rate of 30-day major and minor complications. CONCLUSIONS: There are insufficient data from RCTs to draw any conclusions regarding the long-term comparative effectiveness beyond 3 years between LRYGB and LSG.
引用
- Lee Y, Doumouras AG, Yu J, et al. Laparoscopic Sleeve Gastrectomy Versus Laparoscopic Roux-en-Y Gastric Bypass: A Systematic Review and Meta-analysis of Weight Loss, Comorbidities, and Biochemical Outcomes From Randomized Controlled Trials. Ann Surg. 2021. PMID: 31693504. doi:10.1097/SLA.0000000000003671
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。